TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Duocort Pharma AB
Closing information (x1000 EUR)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
1,340
|
1,690
|
1,610 |
| Financial expenses |
1
|
64
|
0 |
| Earnings before taxes |
8,145
|
997
|
954 |
| EBITDA |
8,732
|
1,865
|
1,728 |
| Total assets |
17,497
|
9,529
|
8,870 |
| Current assets |
17,497
|
8,926
|
7,516 |
| Current liabilities |
1,743
|
66
|
661 |
| Equity capital |
15,755
|
9,463
|
8,208 |
| - share capital |
10
|
10
|
10 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
90.0%
|
99.3%
|
92.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
607.8%
|
59.0%
|
59.3% |
| Return on assets (ROA) |
46.6%
|
11.1%
|
10.8% |
| Current ratio |
1003.8%
|
13524.2%
|
1137.1% |
| Return on equity (ROE) |
51.7%
|
10.5%
|
11.6% |
| Change turnover |
-319
|
17
|
-56 |
| Change turnover % |
-19%
|
1%
|
-3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.